Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Green

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of the Air & Waste Management Association (1995)|January 11, 2017
Tracking Regional Background in a Haze Attribution ExperimentW H White, E S Macias, L A de P Vasconcelos, et al.
Journal of Medical Internet Research|May 24, 2023
Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods ApproachSophie M C Green, David P French, Louise H Hall, et al.
Hereditary Cancer in Clinical Practice|August 23, 2022
Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providersKelly E Lloyd, Robbie Foy, Louise H Hall, et al.
British Journal of Cancer|September 30, 2010
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsY C Cheng, V Valero, M L Davis, et al.
Journal of Cancer Survivorship : Research and Practice|October 19, 2021
Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelinesLouise H Hall, Natalie V King, Christopher D Graham, et al.
Journal of the Air & Waste Management Association (1995)|September 11, 2015
Middle- and Neighborhood-Scale Variations of PM10 Source Contributions in Las Vegas, NevadaJ C Chow, J G Watson, M C Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2008
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumabF Peintinger, A U Buzdar, H M Kuerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2008
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlationsM Cristofanilli, P Morandi, S Krishnamurthy, et al.
BMC Health Services Research|August 24, 2022
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation StrategySophie M C Green, David P French, Christopher D Graham, et al.
British Journal of Health Psychology|May 13, 2025
Acceptability of acceptance and commitment therapy for medication-decision-making and quality of life in women with breast cancer: A qualitative process evaluationSophie M C Green, Louise H Hall, Rachel Ellison, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of the Air & Waste Management Association (1995)|January 11, 2017
Tracking Regional Background in a Haze Attribution ExperimentW H White, E S Macias, L A de P Vasconcelos, et al.
Journal of Medical Internet Research|May 24, 2023
Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods ApproachSophie M C Green, David P French, Louise H Hall, et al.
Hereditary Cancer in Clinical Practice|August 23, 2022
Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providersKelly E Lloyd, Robbie Foy, Louise H Hall, et al.
British Journal of Cancer|September 30, 2010
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsY C Cheng, V Valero, M L Davis, et al.
Journal of Cancer Survivorship : Research and Practice|October 19, 2021
Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelinesLouise H Hall, Natalie V King, Christopher D Graham, et al.
Journal of the Air & Waste Management Association (1995)|September 11, 2015
Middle- and Neighborhood-Scale Variations of PM10 Source Contributions in Las Vegas, NevadaJ C Chow, J G Watson, M C Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2008
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumabF Peintinger, A U Buzdar, H M Kuerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2008
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlationsM Cristofanilli, P Morandi, S Krishnamurthy, et al.
BMC Health Services Research|August 24, 2022
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation StrategySophie M C Green, David P French, Christopher D Graham, et al.
British Journal of Health Psychology|May 13, 2025
Acceptability of acceptance and commitment therapy for medication-decision-making and quality of life in women with breast cancer: A qualitative process evaluationSophie M C Green, Louise H Hall, Rachel Ellison, et al.
Pageof 6